Cerebrospinal fluid HIV-1 viral load during treatment of cryptococcal meningitis

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 5, 2010, Pages 668-669

  Brouwer, Annemarie E ^a,b,c   Teparrukkul, Praprit ^d   Rajanuwong, Adul ^d   Chierakul, Wirongrong ^c   Mahavanakul, Weera ^d   Chantratita, Wasun ^e   White, Nicholas J ^c,f   Harrison, Thomas S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Sappasitthiprasong Hospital   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

BACTERIAL MENINGITIS; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CRYPTOCOCCUS NEOFORMANS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LETTER; LYMPHOCYTE ACTIVATION; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS LOAD;

CRYPTOCOCCUS NEOFORMANS; HIV INFECTIONS; HIV-1; HUMANS; MENINGITIS, CRYPTOCOCCAL; RNA, VIRAL;

EID: 77950278667     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181ba489a     Document Type: Letter

References (10)

1. Gisslen M, Fuchs D, Svennerholm B, et al. Cerebrospinal fluid viral load, intrathecal immu-noactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr. 1999;21:271-276.
2. Lederman MM, Georges DL, Kusner DJ, et al. Mycobacterium-tuberculosis and its purified protein derivative activate expression of the human- immunodeficiency-virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1994;7: 727-733.
3. Pettoellomantovani M, Casadevall A, Kollmann TR, et al. Enhancement of HIV-1 infection by the capsular polysaccharide of cryptococcus-neoformans. Lancet. 1992;339: 21-23.
4. Harrison TS, Nong SH, Levitz SM. Induction of human immunodeficiency virus type 1 expression in monocytic cells by Cryptococcus neoformans and Candida albicans. J Infect Dis. 1997;176:485-491.
5. Morris L, Silber E, Sonnenberg P, et al. High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis. J Infect Dis. 1998;177:473-476.
6. Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev. 2001;14:753-777.
7. Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004;363:1764-1767.
8. Siddiqui AA, Brouwer AE, Wuthiekanun V, et al. IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol. 2005;174: 1746-1750.
9. Casadevall A, Perfect JR. Cryptococcus Neo-formans. Washington, DC: American Society for Microbiology; 1998;407-456.
10. Poli G. Cytokines and the human immunodeficiency virus: from bench to bedside. Eur J Clin Invest. 1999;29:723-732